Binding of [3H](+)-BW373U86 to δ-opioid receptors in rat brain membranes

European Journal of Pharmacology

Volumn 310, Issue 2-3, 1996, Pages 263-267

  Campa, Michael J ^a   McNutt, Robert W ^b   Hill, John A ^b   Patz, Edward F ^a   Chang, Kwen Jen ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Burroughs Wellcome Co   (United States)

^c Delta Pharmaceuticals Inc   (United States)

Author keywords

BW373U86; G protein; Radioligand binding; Opioid receptor

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; DELTORPHIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE; NALTRIBEN; NALTRINDOLE; OPIATE; OPIATE RECEPTOR; BENZAMIDE DERIVATIVE; DELTA OPIATE RECEPTOR; PIPERAZINE DERIVATIVE; TRITIUM;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BRAIN; DRUG POTENTIATION; METABOLISM; STEREOISOMERISM;

ANIMALS; BENZAMIDES; BRAIN; PIPERAZINES; RATS; RECEPTORS, OPIOID, DELTA; STEREOISOMERISM; TRITIUM;

EID: 0030605934     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00483-9     Document Type: Article

References (15)

1. Bishop, M.J. and R.W. McNutt, 1995, An efficient synthesis of the benzhydrylpiperazine delta opioid agonist (+)-BW373U86, Bioorg. Med. Chem. Lett. 5, 1311.
2. Chang, K.-J., G.C. Rigdon, J.L. Howard and R.W. McNutt, 1993, A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86, J. Pharmacol. Exp. Ther. 267, 852.
3. Chen, Y., A. Mestek, J. Liu, J.A, Hurley and L. Yu, 1993, Molecular cloning and functional expression of a μ-opioid receptor from rat brain, Mol. Pharmacol. 44, 8.
4. 50) of an enzymatic reaction, Biol. Pharmac. 22, 3099.
5. Childers, S.R., L.M. Fleming, D.E. Selley, R.W. McNutt and K.-J. Chang, 1993, BW373U86: a nonpeptidic δ-opioid agonist with novel receptor G-protein-mediated actions in rat brain membranes and neuroblastoma cells, Mol. Pharmacol. 44, 827.
6. Comer, S.D., R.W. McNutt, K.-J. Chang, B.R. De Costa, H.I. Mosberg and J.H. Woods. 1993, Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors, J. Pharmacol. Exp. Ther. 267, 866.
7. Evans, C.J., D.E.J. Keith, H. Morrison, K. Magendzo and R.H. Edwards, 1992, Cloning of a delta opioid receptor by functional expression, Science 258, 1952.
8. 284 of the human δ opioid receptor is required for SNC121 binding but not binding of pCl-DPDPE, deltorphin II or naltrindole, Analgesia 1, 539.
9. Meng, F., G.-X. Xie, R.C. Thompson, A. Mansour, A. Goldstein, S.J. Watson and H. Akil, 1993, Cloning and pharmacological characterization of a rat κ opioid receptor, Proc. Natl. Acad. Sci. USA 90, 9954.
10. Mosberg, H.I., R. Hurst, V.J. Hruby, K. Gee, H.I. Yamamura, J.I. Galligan and T.F. Burks, 1983, Bis-penicillamine enkephalins possess highly improved specificity toward δ opioid receptors, Proc. Natl. Acad. Sci. USA 80, 5871.
11. 1 opioid receptor antagonist in the mouse spinal cord. Life Sci. 52, 769.
12. Vaughn, L.K., W.S. Wire, P. Davis, Y. Shimohigashi, G. Toth, R.J. Knapp, V.J. Hruby, T.F. Burks and H.I. Yamamura, 1990, Differentiation between rat brain and mouse vas deferens δ opioid receptors, Eur. J. Pharmacol. 177, 99.
13. Wild, K.D., V.J. Carlisi, H.I. Mosberg, W.D. Bowen, P.S. Portoghese, M. Sultana, A.E. Takemori, V.J. Hruby and F. Porreca, 1993a, Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens, J. Pharmacol. Exp. Ther. 264, 831.
14. Wild, K.D., L. Fang, R. McNutt W., K.-J. Chang, G. Toth, A. Borsodi, H.I. Yamamura and F. Porreca, 1993b, Binding of BW373U86, a non-peptidic δ opioid receptor agonist, is not regulated by guanine nucleotides and sodium, Eur. J. Pharmacol. 246, 289.
15. Wong, C.-S., Y.-F. Su, D. Watkings and K.-J. Chang, 1994, Opioid agonist binding affinity is increased by magnesium in the presence of guanosine diphosphate but decreased by magnesium in the presence of guanyl-5′-yl imidodiphosphate, J. Pharmacol. Exp. Ther. 268, 653.